NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia to Unveil Novel Data on Genomic Risk and Treatment Disparities in Early-Stage Breast Cancer at 2025 ASCOยฎ Annual Meeting
FLEX Study reaches milestone of 20,000 enrolled patients, providing new insights on genomic testing across diverse patient populations IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ May 15, 2025 โ Agendiaยฎ, Inc., announced today that Read More
Agendia to Present FLEX Study Data on Impact of BluePrint at ESMO Breast Cancer 2025
Real-world analysis shows BluePrintยฎ identifies chemotherapy-sensitive Basal-type tumorsย among MammaPrintยฎ High Risk HR+ HER2- breast cancers, supporting more personalizedย treatment strategies.ย IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ May 6, 2025 โ Agendiaยฎ, Inc., Read More
Agendia Spotlights New Data on Genomic Testing at 26th American Society of Breast Surgeons Annual Meeting
Poster presentation to highlight new data on MammaPrintยฎ and BluePrintยฎ utility for informing axillary surgery decisions in the neoadjuvant setting. Agendia to present at Breast Fellows University Annual Meeting and host Educational Dinner Symposium Read More
Newsroom
News, Stories & Breast Cancer Blog
Agendia Named 2025 โBest Overall Genomics Companyโ By MedTech Breakthrough
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies ย MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital Read More
The Endocrine System and Breast Cancer Overview
The endocrine system is a series of glands responsible for creating and distributing hormones throughout the body, chemical messengers of sorts.ย This important system plays a role in many bodily functions, including regulating metabolism, Read More
Disparities in Breast Cancer Care, Genomic Insights and Early Detection
By Ryan Scott | March 19, 2025 Black women face a 40% higher mortality rate from breast cancer compared with other groups, according to the Breast Cancer Research Foundation, highlighting a disparity in detection, Read More
Breast Cancer Statistics 2024
Authors Angela N. Giaquinto MSPH | Hyuna Sung PhD | Lisa A. Newman MD, MPH | Rachel A. Freedman MD, MPH | Robert A. Smith PhD | Jessica Star MA, MPH | Ahmedin Jemal Read More
Anthracyclines and Treatment of Early-Stage Breast Cancer
For decades, anthracyclines have played an important role in treating early-stage breast cancer. But whether this class of drugs should continue to be recommended in early disease given that other available therapies are less Read More
Improving Tailored Treatment Plans in HR+ and HER2- Early Breast Cancer
Genomic profiling in the FLEX trial predicted chemotherapy response in HR+, HER2- breast cancer, which could enable tailored treatment plans. Inย an abstractย presented at theย 2024 San Antonio Breast Cancer Symposium, researchers used genomic profiling in Read More
Healthcare Tech Outlook Named Agendia as One of the Top 10 Precision Oncology Solutions Providers in 2024
We are happy to announce Agendia has been named one of the Top 10 Precision Oncology Solutions Providers in 2024. Agendia is proud to be a part of the precision medicine movement with our Read More